Wells Fargo & Company Profound Medical Corp. Transaction History
Wells Fargo & Company
- $407 Billion
- Q2 2024
A detailed history of Wells Fargo & Company transactions in Profound Medical Corp. stock. As of the latest transaction made, Wells Fargo & Company holds 4,784 shares of PROF stock, worth $39,228. This represents 0.0% of its overall portfolio holdings.
Number of Shares
4,784
Previous 4,784
-0.0%
Holding current value
$39,228
Previous $40,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding PROF
# of Institutions
40Shares Held
8.98MCall Options Held
22.9KPut Options Held
0-
Gagnon Securities LLC1.51MShares$12.4 Million2.99% of portfolio
-
Fil LTD Hamilton, D01.51MShares$12.3 Million0.01% of portfolio
-
Letko, Brosseau & Associates Inc Montreal, A81.2MShares$9.83 Million0.2% of portfolio
-
Gagnon Advisors, LLC747KShares$6.13 Million5.18% of portfolio
-
Timelo Investment Management Inc.726KShares$5.95 Million3.53% of portfolio
About Profound Medical Corp.
- Ticker PROF
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 20,851,300
- Market Cap $171M
- Description
- Profound Medical Corp., together with its subsidiaries, operates as a commercial-stage medical device company that develops magnetic resonance guided ablation procedures for treatment of prostate disease, uterine fibroids, and palliative pain treatment in Canada, Germany, the United States, and Finland. Its lead product TULSA-PRO system used for...